• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Pihlajalinna

10.46 EUR

+0.19 %

9,156 following

PIHLIS

NASDAQ Helsinki

Health Care Providers

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Analyst consensus
Compare
+0.19 %
-4.56 %
-18.60 %
-28.36 %
-24.48 %
-29.80 %
+13.82 %
-10.29 %
-9.04 %

Pihlajalinna produces private social and health services. The company offers comprehensive medical center and hospital services as well as occupational health and insurance cooperation services. In addition, Pihlajalinna offers services for welfare areas, such as social and health care service production models. The company was founded in 2001 and its head office is located in Tampereella, Finland.

Read more
Market cap
236.61M EUR
Turnover
16.07K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Accumulate
Target price
Updated
28.04.2026
Disclaimer
Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
These don’t cost much of anything when you consider the production costs. I run a medical clinic myself, and the cost breakdown is as follows: Procedure set (sterile disposable instruments): €12-20 Anesthetic: a lidocaine ampoule is around €4, lidocaine-adrenaline €8-10 Sutures: ...
5/16/2026, 4:20 PM
by JNivala
27
Pihlajalinna shareholders are once again in line for dividends through partially questionable means. A practitioner at Pihlajalinna billed 4,600 euros for a 20-minute mole removal after noticing that the payer was the insurance company Pohjantähti. I assume a certain percentage of...
5/16/2026, 10:40 AM
by Nordman09
10
Yeah, the way those big firms operate is a total rip-off. I had a follow-up appointment with an occupational health doctor scheduled for a week later. I sent a message saying the issue had cleared up and there was no need for the visit, and the doctor said okay, let’s cancel the ...
5/16/2026, 8:53 PM
by Inspired
3
And here are Roni’s comments on the morning’s result Pihlajalinna’s Q1 result fell slightly short of our expectations in terms of operational figures, as revenue contracted more sharply than our forecasts. Profitability, however, was at the level of the comparison period, which can...
4/28/2026, 6:00 AM
by Sijoittaja-alokas
3
Here is Roni’s pre-earnings report, as Pihlajalinna releases its Q1 results on Tuesday, April 28. With the termination of outsourcing contracts, revenue and earnings will decrease significantly. Additionally, the demand environment for private health services has been weak, and we...
4/20/2026, 5:06 AM
by Sijoittaja-alokas
3
I have to say that the billing doctor used the completely wrong code there; that code is for a major procedure performed in an operating room.
5/16/2026, 7:31 PM
by Niinpä
2
Here are Roni’s comments regarding Pihlajalinna’s change negotiations. As a result of the negotiations, an estimated 220 positions will be reduced from the company, which is slightly less than the maximum estimate of approximately 270 positions announced at the end of March. Through...
5/6/2026, 4:48 AM
by Sijoittaja-alokas
2
Read more on our forum
Roni Peuranheimo
Roni Peuranheimo

Analyst

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
23.7.
2026

Interim report Q2'26

28.10.
2026

Interim report Q3'26

Regulatory press release5/6/2026, 12:00 PM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna
Regulatory press release5/6/2026, 12:00 PM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna
Regulatory press release5/6/2026, 12:00 PM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release5/6/2026, 12:00 PM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna
Regulatory press release5/6/2026, 12:00 PM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna
Regulatory press release5/6/2026, 12:00 PM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna
Regulatory press release5/6/2026, 5:00 AM

Transfer of Pihlajalinna’s own shares

Pihlajalinna
Regulatory press release4/30/2026, 11:30 AM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna
Regulatory press release4/30/2026, 11:30 AM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna
Regulatory press release4/28/2026, 5:00 AM

Pihlajalinna Interim Report 1 January–31 March 2026: Revenue declined as expected due to expiry of outsourcing agreements, margin remained at the previous year's level

Pihlajalinna
Press release4/15/2026, 7:00 AM

Pihlajalinna Plc publishes Interim Report for January 1–March 31, 2026, on Tuesday, 28 April 2026

Pihlajalinna
Regulatory press release3/31/2026, 2:00 PM

Pihlajalinna revises its financial reporting structure and provides comparative segment information for 2025

Pihlajalinna
Regulatory press release3/31/2026, 11:00 AM

Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors of Pihlajalinna Plc

Pihlajalinna
Regulatory press release3/11/2026, 4:05 PM

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna
Regulatory press release3/11/2026, 4:00 PM

Pihlajalinna Plc: Flagging announcement in accordance with Chapter 9, Section 10 of the Securities Markets Act

Pihlajalinna
Regulatory press release3/10/2026, 6:00 AM

Pihlajalinna has published the 2025 Annual Report

Pihlajalinna
Regulatory press release3/6/2026, 6:00 AM

Pihlajalinna Plc: Notice to Annual General Meeting

Pihlajalinna
Regulatory press release2/12/2026, 6:30 AM

Change in Pihlajalinna’s Management Team: Heikki Tarkkila will assume the role of Chief Commercial Officer

Pihlajalinna
Regulatory press release2/12/2026, 6:15 AM

Pihlajalinna to launch long-term share-based incentive plan performance period 2026–2028

Pihlajalinna
Regulatory press release2/12/2026, 6:10 AM

Pihlajalinna to redeem its hybrid bond

Pihlajalinna